PharmaLytica 2018 Closes on a High Note

Tuesday, August 21, 2018 Drug News
Email Print This Page Comment bookmark
Font : A-A+

HYDERABAD, India, August 21, 2018 /PRNewswire/ --

Witnessed 24% increase in visitor

footfall in its 5th edition in Hyderabad 

  • A premier industry event from the organisers of CPhI and P-MEC India
  • Showcased the latest
    in Quality Assurance, Technology, Quality Culture and Regulatory & Compliance Standards for the Pharmaceutical Sector
  • Witnessed participation from over 150 exhibitors 
  • Set to further expand its reach into the Western region by hosting in Mumbai from 2019

The fifth edition of PharmaLytica, hosted by UBM India, successfully concluded at the Hitex Exhibition Centre recently. This year, PharmaLytica witnessed a massive turnout from exhibitors of the Pharma industry with a whooping increase of 24% in visitor footfalls.

     (Logo: https://mma.prnewswire.com/media/675607/UBM_Logo.jpg )

     (Logo: https://mma.prnewswire.com/media/726649/PharmaLytica_2018.jpg )

Positioned as India's most Comprehensive Analytical, Bio-technology, Lab equipment, Pharma Machinery and Pharma Packaging event, PharmaLytica 2018, brought the pharmaceutical fraternity under one roof to witness the latest industry trends, innovations and conduct business.

A series of insightful sessions and panel discussions convened by industry experts were organized to discuss the trending subjects in Quality Assurance, Technology, Quality Culture and Regulatory & Compliance Standards in the Pharmaceutical Sector. The conference focused on the growth phase, challenges and how the industry can again truly distinguish itself in the global pharma industry in the years to come.

The expo is set to get bigger by further expanding its reach into the Western region with its strong pharma market by hosting PharmaLytica for the first time in Mumbai from 10 - 12 June, 2019. While targeting the South-West market with sectors such as Lab & Analytical, Pharma Machinery & Packaging, PharmaLytica will also launch API and Excipients zone to continue it's pre-eminence in this region.

Speaking on the conclusion of the fifth edition of PharmaLytica in Hyderabad 2018, Mr. Yogesh Mudras, Managing Director, UBM India said, "We are thrilled that PharmaLytica 2018 witnessed such a great participation from Indian and global firms. At UBM India, we are committed to encouraging novelty in products and an exchange of ideas within the framework of our exhibitions. We are looking forward to taking this prestigious platform to the next level in the coming years. Given our growing and unique offering in the Pharma domain, we are pleased to announce PharmaLytica's move to Mumbai in 2019, aiming to add substantial value to the strong Western market in addition to the Southern one."

Speaking at the event, Mr. Uday Bhaskar, Director General, Pharmexcil said, "I'm happy to be associated with PharmaLytica which has been helping the industry and visitors to understand the latest equipment and trends. It is the one place where they witness an entire range of the industry and get to know about new developments. After all, machinery plays an important role as per FDA guidelines, and this expo has been facilitating machinery manufacturers and product manufacturers. I'm happy that UBM India did a meticulous job in this domain."

About UBM Asia: 

UBM Asia recently became part of Informa PLC, a leading B2B information services group and the largest B2B Events organiser in the world. Please visit http://www.ubm.com/asia for more information about our presence in Asia.

About PharmaLytica: 

PharmaLytica is organised by UBM, which in June 2018 combined with Informa PLC to become a leading B2B information services group and the largest B2B Events organiser in the world. Please visit http://www.ubm.com/india for more information about our presence in India.

For any media queries please contact: UBM India Roshni Mitra roshni.mitra@ubm.com

Mili Lalwani mili.lalwani@ubm.com

Prachi Kumar prachi.kumar@ubm.com +91-7718866668 UBM India



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store